PatientsLikeMe ™

PD
Join Now (It's free!)

Already a member? Log in

Share your real-world treatment experience
with patients just like you.
Filter page content by community
Parkinson's
Find out more about the PatientsLikeMe
Parkinson's Community

See More Treatments

See all treatments in the PatientsLikeMe system shared by patients just like you.


Brand Names: Inderal, Inderal LA, InnoPran XL, Syprol

What is Propranolol? Propranolol is a non-selective beta blocker used in the treatment of hypertension, angina, and other heart conditions. It was the first successful beta blocker in medicine. Read more...Click to read more below

See more information, including instructions, precautions, side effects, and interactions.


Reasons Taken

34 patients in the community are taking or have taken Propranolol.

Reason # Patients Percentage of patients
Other 13 38%
Treat Parkinson's 8 23%
Tremors 4 11%
Hand tremor 3 8%
Anxiety 2 5%
Hypertension 1 2%
Headaches/ Migraines 1 2%

Dosages

Based on the patients currently taking Propranolol.

Top 10 (Show all)

All (Show Top 10)

  0 mg day 0 mg none 1 mg day 4 mg day 20 mg day 30 mg day 40 mg day 60 mg day 80 mg day 120 mg day 280 mg day 480 mg day 1600 mg day
  1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1 5 Number of Patients: 5 4 Number of Patients: 4 6 Number of Patients: 6 3 Number of Patients: 3 1 Number of Patients: 1 1 Number of Patients: 1 1 Number of Patients: 1  

Duration

How long current patients have been taking Propranolol or how long patients were taking Propranolol before stopping.

Currently taking Propranolol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
2
0
3
3
5
8

Stopped taking Propranolol

0-1 month 1-3 months 3-6 months 6 months-1year 1-2 years 2 years or more
0
2
0
0
2
3
Why Patients Stopped Taking Propranolol (multiple reasons could be selected)
Reason # Patients Percentage of patients
Doctor's advice 6 75% Doctor's advice: 75%
Not indicated 2 25% Not indicated: 25%
Other 1 13% Other: 13%


Back to top